|
Hospital stay for the original infection, median (IQR)
|
15.96 (9.96–23.75)5
|
18.54 (11.96–27.04)1
|
15.71 (9.83–23.21)3
|
|
Days from discharge from hospital to re-positive test, median (IQR)
|
NA
|
11.00 (9.00–17.00)2
|
NA
|
|
Hospital stay for re-positive test, median (IQR)
|
NA
|
10.63 (7.67–15.63)4
|
NA
|
|
Sex, no. (%)
|
|
Male
|
9433 (46.51%)
|
1082 (43.88%)
|
8351 (46.88%)
|
|
Female
|
10,847 (53.49%)
|
1384 (56.12%)
|
9463 (53.12%)
|
|
Age, no. (%)
|
|
0~9
|
124 (0.61%)
|
6 (0.24%)
|
118 (0.66%)
|
|
10~19
|
172 (0.85%)
|
23 (0.93%)
|
149 (0.84%)
|
|
20~29
|
913 (4.50%)
|
142 (5.76%)
|
771 (4.33%)
|
|
30~39
|
2662 (13.13%)
|
335 (13.58%)
|
2327 (13.06%)
|
|
40~49
|
3572 (17.61%)
|
370 (15.00%)
|
3202 (17.97%)
|
|
50~59
|
4941 (24.36%)
|
588 (23.84%)
|
4353 (24.44%)
|
|
60~69
|
5319 (26.22%)
|
668 (27.09%)
|
4651 (26.11%)
|
|
70~79
|
1973 (9.73%)
|
254 (10.30%)
|
1719 (9.65%)
|
|
≥ 80
|
562 (2.77%)
|
80 (3.24%)
|
482 (2.71%)
|
|
Symptoms of first infection, no. (%)
|
*
|
*
| |
|
Asymptomatic
|
543 (2.68%)
|
6 (0.24%)
|
537 (3.01%)
|
|
Mild
|
10,304 (50.83%)
|
1220 (49.67%)
|
9084 (51.00%)
|
|
Moderate
|
6614 (32.63%)
|
874 (35.59%)
|
5740 (32.22%)
|
|
Severe
|
2365 (11.67%)
|
296 (12.05%)
|
2069 (11.61%)
|
|
Critical
|
379 (1.87%)
|
59 (2.40%)
|
320 (1.80%)
|
